Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03267732
PHASE1

A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)

Sponsor: Eli Lilly and Company

View on ClinicalTrials.gov

Summary

To evaluate the pharmacokinetics of single and multiple doses of pegilodecakin in healthy participants.

Official title: A Phase 1 Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of AM0010 in Healthy Adult Subjects

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2017-09-05

Completion Date

2017-10-17

Last Updated

2026-10-02

Healthy Volunteers

Yes

Interventions

BIOLOGICAL

Pegilodecakin

Administered SQ

Locations (1)

PPD Development

Austin, Texas, United States